Traws Pharma (TRAW) Short-term Investments (2013 - 2014)
Traws Pharma (TRAW) posted quarterly Short-term Investments of $15.0 million for Q3 2014, down 62.49% year-over-year from $40.0 million in Q3 2013, and little changed quarter-over-quarter from $15.0 million in Q2 2014.
Traws Pharma (TRAW) Short-term Investments (2013 - 2014) Analysis & Trends
Traws Pharma (TRAW) has reported Short-term Investments for 2 consecutive years, with $15.0 million the latest figure, recorded in Q3 2014.
- In Q3 2014, Short-term Investments fell 62.49% year-over-year to $15.0 million; the TTM figure through Sep 2014 stood at $15.0 million (down 62.49% YoY), while the FY2013 annual figure was $40.0 million, changed N/A from the prior year.
- Short-term Investments was little changed at $15.0 million in Q3 2014 per TRAW's latest filing, from $15.0 million in the prior quarter.
- Across five years, Short-term Investments topped out at $40.0 million in Q4 2013 and bottomed at $15.0 million in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 15.00 Mn |
| Jun 30, 2014 | 15.00 Mn |
| Mar 31, 2014 | 30.00 Mn |
| Dec 31, 2013 | 39.99 Mn |
| Sep 30, 2013 | 39.99 Mn |